Skip to main content
. 2021 Aug 11;15(6):910–917. doi: 10.1016/j.pcd.2021.07.013

Table 2.

Baseline characteristics of the low and high HbA1c group.

Parameter Studies Low HbA1c
High HbA1c
p-Value
N N (mean)/ (%) N (mean)/ (%)
Age (year) 4 [19,[21], [22], [23]] 607 61.63 383 67.83 0.107
Male (%) 5 [[19], [20], [21], [22], [23]] 662 56.52% 399 57.36% 0.891
Comorbidities
HNT (%) 4 [19,20,21,22] 409 38.88% 157 59.50% 0.062
CVD (%) 3 [19,20,22] 281 17.10% 93 27.27% 0.363
CKD (%) 3 [[20], [21], [22]] 328 3.03% 128 12.50% 0.493
COPD (%) 3 [19,20,22] 281 13.43% 93 19.67% 0.698
Presentation
Fever (%) 4 [[19], [20], [21], [22]] 409 66.15% 157 72.55% 0.572
Fatigue (%) 2 [21,22] 273 36.85% 112 40.85% 0.873
Cough (%) 3 [19,21,22] 354 64.80% 141 59.70% 0.693
Diarrhea (%) 3 [19,21,22] 354 19.00% 141 13.80% 0.507
Laboratories values
Leukocyte count (×109/L) 3 [19,22,23] 479 6.4 319 8.1 0.039
Hb (g/L) 2 [21,22] 273 127.75 112 128.25 0.846
PLT (×109/L) 3 [19,21,22] 354 225.77 141 211.9 0.726
PT (s) 2 [21,22] 273 13.9 112 14.05 0.804
APTT (s) 2 [21,22] 273 39.2 112 38.45 0.532
Fbg (g/L) 2 [22,23] 398 4.96 290 5.06 0.896
D-dimer (mg/L) 3 [21,23] 526 1.14 354 1.6 0.473
CRP (mg/L) 2 [19,21,23] 462 7.95 335 11.45 0.471
PCT (ng/mL) 3 [19,21,22] 354 0.13 141 0.49 0.376
Ferritin (μg/L) 2 [22,23] 398 688.75 290 1134.9 0.210
Interleukin-6 (pg/mL) 3 [21,23] 526 26.24 354 36.63 0.645
TNFα (pg/mL) 2 [21,22] 273 8.15 112 9.55 0.509
Creatinine (μmol/L) 2 [21,22] 273 74.50 112 76 0.873
Urea nitrogen (mmol/L) 2 [21,22] 273 4.90 112 6.65 0.340
ALT (U/L) 2 [21,22] 273 21.00 112 22.75 0.232
AST (U/L) 2 [21,22] 273 27.00 112 29.5 0.718
Triglyceride (mmol/L) 2 [22,23] 398 4.08 290 5.01 0.846
ICU admission (%) 4 [[19], [20], [21], [22]] 409 17.40% 157 27.88% 0.546
Mechanical ventilation (%) 2 [22,23] 398 43.10% 290 65.65% 0.310

HbA1c, glycated hemoglobin; HTN, hypertension; CVD, cardiovascular disease; CK, chronic kidney disease; COPD, chronic obstructive pulmonary disease; Hb, hemoglobin; PLT, platelet count; PT, prothrombin time; APTT, activated partial thromboplastin time; Fbg, fibrinogen; CRP, C-reactive protein; PCT, procalcitonin; TNFα, tumor necrosis factor-a; ALT, alanine aminotransferase; AST, aspartate aminotransferase.